Sign In
Buy BIIB
$207.94
+1.66 (+0.80%)
At Close: Aug 07, 2026
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biogen
09:40am, Wednesday, 03'rd Jul 2024
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Biogen To Contact Him Directly To Discuss Their Options If you suf
Lilly follows Biogen-Eisai in securing US FDA approval for Alzheimer's drug
08:34am, Wednesday, 03'rd Jul 2024
Eli Lilly's Kisunla secured standard approval from the U.S. Food and Drug Administration on Tuesday for slowing the progression of Alzheimer's disease.
Levi & Korsinsky Reminds Biogen Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2024 - BIIB
05:30am, Wednesday, 03'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
UPCOMING BIIB DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Biogen Inc. Investors to Join the Class Action Lawsuit!
05:00am, Wednesday, 03'rd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 3, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Biogen Inc. ("Bio
Lost Money on Biogen Inc.(BIIB)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
11:30pm, Tuesday, 02'nd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
BIIB Investors Have Opportunity to Lead Biogen Inc. Securities Fraud Lawsuit
11:00pm, Tuesday, 02'nd Jul 2024
LOS ANGELES , July 2, 2024 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit again
Biogen Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - BIIB
05:10pm, Tuesday, 02'nd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
Investors who lost money on Biogen Inc.(BIIB) should contact Levi & Korsinsky about pending Class Action - BIIB
05:00pm, Tuesday, 02'nd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
LOS ANGELES, CA / ACCESSWIRE / July 2, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Biogen Inc. ("Biogen" or "the Com
Biogen Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB
04:30pm, Tuesday, 02'nd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
Lost Money on Biogen Inc. (BIIB)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
04:30pm, Tuesday, 02'nd Jul 2024
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
BIIB STOCKHOLDERS: Lead Plaintiff Deadline Approaching in Biogen Inc. Class Action; Contact Robbins LLP
04:02pm, Tuesday, 02'nd Jul 2024
SAN DIEGO, July 02, 2024 (GLOBE NEWSWIRE) -- Robbins LLP reminds investors that a shareholder filed a class action on behalf of persons and entities that purchased or otherwise acquired Biogen Inc.
Eli Lilly Snags Long-Awaited Alzheimer's Drug Approval, Rivaling Biogen, Eisai
02:16pm, Tuesday, 02'nd Jul 2024
Eli Lilly won FDA approval for its Alzheimer's treatment, donanemab, on Tuesday. But Eli Lilly stock remained in the red.
Shareholders that lost money on Biogen Inc. (BIIB) should contact Levi & Korsinsky about pending Class Action - BIIB
12:35pm, Tuesday, 02'nd Jul 2024
NEW YORK, July 02, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB) of a class action securities lawsuit.
